H49.811 Kearns-Sayre syndrome, right eye

Name of the Condition

• Kearns-Sayre syndrome, right eye

Summary

Kearns-Sayre syndrome is a rare mitochondrial disorder characterized by progressive external ophthalmoplegia (weakness of the eye muscles), pigmentary retinopathy, and cardiac conduction defects. This specific code applies to manifestations affecting the right eye. The condition typically presents before age 20 and may involve systemic manifestations such as ataxia, hearing loss, or endocrine abnormalities. It is caused by deletions in mitochondrial DNA and follows a progressive course.

Causes

Kearns-Sayre syndrome is caused by large deletions in mitochondrial DNA, which disrupt energy production in cells. These deletions are usually sporadic and not inherited from parents. The exact trigger for these deletions is not fully understood, but they result in impaired mitochondrial function affecting multiple organ systems, including the ocular structures.

Risk Factors

• Age of onset (typically before 20 years)
• Sporadic mitochondrial DNA deletions
• Family history of mitochondrial disorders (rare)

Symptoms

• Progressive external ophthalmoplegia (eye muscle weakness) affecting the right eye
• Pigmentary retinopathy (retinal changes) in the right eye
• Cardiac conduction defects (e.g., heart block)
• Ataxia (loss of coordination)
• Hearing loss
• Endocrine abnormalities (e.g., diabetes, thyroid issues)
• Short stature
• Cognitive impairment (in some cases)

Diagnosis

Diagnosis is based on clinical features (ophthalmoplegia, retinopathy) and confirmed by genetic testing for mitochondrial DNA deletions. Imaging studies may be used to evaluate cardiac or neurological involvement. Laboratory tests can assess for systemic manifestations such as endocrine abnormalities.

Treatment Options

Treatment focuses on managing symptoms and complications. This may include cardiac monitoring for conduction defects, endocrine management, physical therapy for ataxia, and visual aids for retinopathy. There is no cure for the underlying mitochondrial disorder.

Prognosis and Follow-Up

The condition follows a progressive course, with symptoms worsening over time. Regular follow-up is essential to monitor cardiac, neurological, and ocular status. Lifespan may be reduced due to complications such as cardiac arrhythmias or respiratory failure.

Complications

• Cardiac conduction defects (e.g., heart block)
• Respiratory failure
• Endocrine disorders (e.g., diabetes)
• Neurological deterioration
• Visual impairment

Lifestyle & Prevention

No specific prevention exists for Kearns-Sayre syndrome due to its genetic basis. Management focuses on symptom control and regular medical monitoring. Avoiding triggers that may exacerbate mitochondrial dysfunction (e.g., certain medications) is advised when possible.

When to Seek Professional Help

Seek immediate medical attention for symptoms such as sudden vision changes, chest pain, shortness of breath, or fainting, which may indicate cardiac or respiratory complications. Regular ophthalmologic and cardiac evaluations are recommended for ongoing management.

Tips for Medical Coders

Use this code for Kearns-Sayre syndrome with right eye involvement. Document the specific eye affected and any associated ocular manifestations. Ensure clinical correlation with systemic features of the syndrome for accurate coding.